Processing

Please wait...

Settings

Settings

1. WO1996003435 - FELINE $g(g)-INTERFERON

Publication Number WO/1996/003435
Publication Date 08.02.1996
International Application No. PCT/GB1995/001731
International Filing Date 21.07.1995
Chapter 2 Demand Filed 24.01.1996
IPC
A61K 38/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/57 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
52Cytokines; Lymphokines; Interferons
555Interferons (IFN)
57IFN-gamma
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/57
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
52Cytokines; Lymphokines; Interferons
555Interferons [IFN]
57IFN-gamma
Applicants
  • Q-ONE BIOTECH LIMITED [GB/GB]; Todd Campus West of Scotland Science Park Glasgow G20 0XA, GB (AllExceptUS)
  • ONIONS, David, Edward [GB/GB]; GB (UsOnly)
  • ARGYLL, David [GB/GB]; GB (UsOnly)
  • LEES, Gillian, Margaret [GB/GB]; GB (UsOnly)
Inventors
  • ONIONS, David, Edward; GB
  • ARGYLL, David; GB
  • LEES, Gillian, Margaret; GB
Agents
  • McCALLUM, William, Potter ; Cruikshank & Fairweather 19 Royal Exchange Square Glasgow G1 3AE, GB
Priority Data
9414752.721.07.1994GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) FELINE $g(g)-INTERFERON
(FR) GAMMA-INTERFERON D'ORIGINE FELINE
Abstract
(EN)
The present invention provides a polynucleotide fragment encoding feline $g(g)-interferon, a recombinant vector comprising such a polynucleotide fragment, a host cell containing said polynucleotide fragment or recombinant vector, a recombinant feline $g(g)-interferon polypeptide, and pharmaceutical compositions comprising recombinant $g(g)-interferon for use as a prophylactic and/or therapeutic agent and also as an adjuvant.
(FR)
Cette invention concerne un fragment polynucléotidique codant un gamma-interféron d'origine féline, un vecteur de recombinaison comprenant un fragment polynucléotidique de ce type, une cellule hôte contenant ledit fragment polynucléotidique ou ledit vecteur de recombinaison, un polypeptide de gamma-interféron d'origine féline obtenu par recombinaison, et des compositions pharmaceutiques comprenant le gamma-interféron de recombinaison utilisé comme agent prophylactique et/ou thérapeutique et également comme adjuvant.
Also published as
Latest bibliographic data on file with the International Bureau